Adprotech Ltd. acquired by Inflazyme Pharmaceuticals Inc.
|
|
|
|
5600 Parkwood Way. Suite 425 Richmond British Columbia V6V 2M2 Canada |
| |
|
|
+1-604-279-8511 |
|
|
+1-604-279-8711 |
|
|
|
|
|
|
|
|
|
inflammation technology platform; complement inhibition and a potential novel clinical compound being developed for the treatment of rheumatoid arthritis | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|